Eli N. Glezer insider trades
Open-market stock purchases and sales by Eli N. Glezer, Chief Scientific Officer at Singular Genomics Systems, Inc, from SEC Form 4 filings since Mar 4, 2022.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- OMIC Singular Genomics Systems, Inc: 3 buys, last Feb 21, 2025